These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10565707)

  • 1. Olanzapine in whole, not half, tablets for psychosis from Alzheimer's dementia.
    Wolfgang SA
    Am J Health Syst Pharm; 1999 Nov; 56(21):2245-6. PubMed ID: 10565707
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.
    Schatz RA
    Ann Pharmacother; 2003 Sep; 37(9):1321-4. PubMed ID: 12921516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.
    Street JS; Clark WS; Gannon KS; Cummings JL; Bymaster FP; Tamura RN; Mitan SJ; Kadam DL; Sanger TM; Feldman PD; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2000 Oct; 57(10):968-76. PubMed ID: 11015815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine for the treatment of monosymptomatic hypochondriacal psychosis.
    Fawcett RG
    J Clin Psychiatry; 2002 Feb; 63(2):169. PubMed ID: 11874224
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease.
    Clark WS; Street JS; Feldman PD; Breier A
    J Clin Psychiatry; 2001 Jan; 62(1):34-40. PubMed ID: 11235926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.
    Cummings JL; Street J; Masterman D; Clark WS
    Dement Geriatr Cogn Disord; 2002; 13(2):67-73. PubMed ID: 11844887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comments on article by Tran and associates, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders".
    Gheuens J; Grebb JA
    J Clin Psychopharmacol; 1998 Apr; 18(2):176-9. PubMed ID: 9555606
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on article by Tran and colleagues, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders".
    Schooler NR
    J Clin Psychopharmacol; 1998 Apr; 18(2):174-6. PubMed ID: 9555605
    [No Abstract]   [Full Text] [Related]  

  • 9. Schizophrenia and schizoaffective disorder treated with high doses of olanzapine.
    Fanous A; Lindenmayer JP
    J Clin Psychopharmacol; 1999 Jun; 19(3):275-6. PubMed ID: 10350037
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease.
    Wolters EC; Jansen EN; Tuynman-Qua HG; Bergmans PL
    Neurology; 1996 Oct; 47(4):1085-7. PubMed ID: 8857751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of monosymptomatic hypochondriacal psychosis treated with olanzapine.
    Weintraub E; Robinson C
    Ann Clin Psychiatry; 2000 Dec; 12(4):247-9. PubMed ID: 11140927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia.
    Marsh L; Lyketsos C; Reich SG
    Psychosomatics; 2001; 42(6):477-81. PubMed ID: 11815682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia.
    Street JS; Clark WS; Kadam DL; Mitan SJ; Juliar BE; Feldman PD; Breier A
    Int J Geriatr Psychiatry; 2001 Dec; 16 Suppl 1():S62-70. PubMed ID: 11748789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic drug choices now include olanzapine.
    Am J Health Syst Pharm; 1996 Dec; 53(23):2784. PubMed ID: 8957340
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of high-dose olanzapine in refractory psychosis.
    Reich J
    Am J Psychiatry; 1999 Apr; 156(4):661. PubMed ID: 10200755
    [No Abstract]   [Full Text] [Related]  

  • 16. Olanzapine and negative symptoms.
    Rosen EH
    J Clin Psychiatry; 1998 Oct; 59(10):537-8. PubMed ID: 9818636
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine for psychosis in patients with Parkinson's disease with and without dementia.
    Aarsland D; Larsen JP; Lim NG; Tandberg E
    J Neuropsychiatry Clin Neurosci; 1999; 11(3):392-4. PubMed ID: 10440017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine: a new typical antipsychotic drug.
    Meltzer HY; Fibiger HC
    Neuropsychopharmacology; 1996 Feb; 14(2):83-5. PubMed ID: 8822530
    [No Abstract]   [Full Text] [Related]  

  • 19. Are the atypical antipsychotic drugs antidepressants?
    Parker G; Malhi G
    J Clin Psychopharmacol; 2002 Feb; 22(1):94-5. PubMed ID: 11799351
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine-induced psychotic mania in bipolar schizo-affective disorder.
    Benazzi F
    Eur Psychiatry; 1999 Nov; 14(7):410-1. PubMed ID: 10733297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.